Do the benefits of daily inhaled steroid treatment of mild asthma outweigh the risks? | Archives of Disease in Childhood

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article Text

Perspectives

Do the benefits of daily inhaled steroid treatment of mild asthma outweigh the risks?

https://doi.org/10.1136/adc.2007.135145

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Competing interests: SP has served on advisory boards for GlaxoSmithKline AstraZeneca and Nycomed, and has received honoraria for educational activities organized by these three companies. His institution has received funding for research from AstraZeneca, GlaxoSmithKline, Merck and Nycomed.

Linked Articles

Atoms
Atoms

Howard Bauchner
Archives of Disease in Childhood 2008; 93 1-1 Published Online First: 21 Jul 2008.
Original article
Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study)

M Turpeinen K Nikander A S Pelkonen P Syvänen R Sorva H Raitio P Malmberg K Juntunen-Backman T Haahtela
Archives of Disease in Childhood 2007; 93 654-659 Published Online First: 18 Jul 2007. doi: 10.1136/adc.2007.116632

Read the full text or download the PDF: